https://www.bloomedi.com/ko/media/breast/korean-societies-issue-first-local-guidance-on-breast-vae-7731f2 MediIndex ko 2026-08-28T02:35:20.823Z 유방병변 진공보조절제술 첫 한국형 권고안, 선택적 시행 원칙 제시 https://www.bloomedi.com/en/media/breast/korean-societies-issue-first-local-guidance-on-breast-vae-7731f2 MediIndex en 2026-08-28T02:35:20.823Z Korean Societies Issue First Local Guidance on Breast VAE https://www.bloomedi.com/ko/media/skin/fda-approves-lisraya-as-first-oral-dermatomyositis-therapy-23bc8b MediIndex ko 2026-08-28T00:35:49.349Z FDA, 피부근염 첫 경구치료제 리스라야 승인 https://www.bloomedi.com/en/media/skin/fda-approves-lisraya-as-first-oral-dermatomyositis-therapy-23bc8b MediIndex en 2026-08-28T00:35:49.349Z FDA Approves Lisraya as First Oral Dermatomyositis Therapy https://www.bloomedi.com/ko/media/breast/rad51d-breast-cancer-mutation-may-predict-chemo-response-b707dc MediIndex ko 2026-08-27T04:35:03.838Z RAD51D 변이 유방암, 수술 전 항암치료 반응 예측 가능성 https://www.bloomedi.com/en/media/breast/rad51d-breast-cancer-mutation-may-predict-chemo-response-b707dc MediIndex en 2026-08-27T04:35:03.838Z RAD51D Breast Cancer Mutation May Predict Chemo Response